BioCorRx Pharmaceuticals Inc. Appoints Neuroscientist Dr. Kate DeVarney to the Board of Directors

Stock Information for Vision Marine Technologies Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Vision Marine Technologies Inc.

Diamond Equity Research Releases Update Note on BioCorRx®, Inc. (OTCQB: BICX)
Diamond Equity Research Initiates Coverage on BioCorRx®, Inc. (OTCQB: BICX)
Fusion Fuel Appoints Luisa Ingargiola to Board of Directors
BioCorRx Reports Business Update for the Second Quarter of 2024
BioCorRx Pharmaceuticals Inc. Awarded New Patent for Novel Compound to Treat Pain, Depression, and Schizophrenia
BioCorRx Reports Business Update for 2023
BioCorRx Pharmaceuticals Inc. Awarded NIDA Grant of Approximately $11 million Over Three Years for Research on BICX104, a Naltrexone Implant in Combination with Bupropion for the Treatment of MUD
BioCorRx Appoints Renowned Investment and Capital Markets Executive Louis Lucido as President

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.